Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Carocare Wellness vs Claya

Carocare Wellness
Graded #378

Lower grade

vs+4.699999999999996
Claya
Graded #264

Higher grade

The verdict

Claya takes it — 62.8/100 to 58.1/100.

Claya grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCarocare Wellness +17
59
42
Dose & formulationClaya +11
64
75
Clinical oversightClaya +13
69
82
Labs & monitoringEven
53
53
FulfillmentClaya +7
60
67
Contract termsClaya +41
20
61
Carocare Wellness · left barClaya · right bar

The numbers

MetricCarocare WellnessClaya
WeighScore58.1/10062.8/100
GradeCC
Scorecard rank#378#264
Semaglutide$170/mo (compounded)$299/mo (compounded)
Tirzepatide$200/mo (compounded)$299/mo (compounded)
Coverage1 stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Carocare Wellness

Graded #378 · C

Strengths

  • Real, named local clinic in Houston with hands-on provider support, in-person visits and Google-reviewed patient experiences
  • Low entry pricing — semaglutide from $170 and tirzepatide from $200 in month 1, with 3-month bundles ($500 / $600) that cut the effective monthly cost
  • Packages include ongoing provider support, supplies and delivery
  • Also offers IV hydration and NAD+ if you want broader wellness services in one place

Where it loses points

  • Houston/Texas only — no nationwide telehealth, so it is not an option outside the local area
  • Dose-escalating pricing climbs steeply (semaglutide reaches $330 by month 5; tirzepatide $425 by month 6)
  • Compounding pharmacy is not named, and there is no LegitScript or published clinical-oversight detail
  • Small single-location operation with no patient portal — booking and support run through Calendly and direct contact
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
Claya

Graded #264 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard